Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models.

European journal of pharmacology - 30 Nov 2001

Smith S R, Denhardt G, Terminelli C

Abstract excerpt

In this report, we describe experiments in which cannabinoid receptor ligands were evaluated for effects on the development of a peritoneal inflammation when elicited in mice with thioglycollate broth or staphylococcus enterotoxin A. The cannabinoid receptor agonists [(-)-11-hydoxy-Delta(8) tetrahydrocannabinol-dimethylheptyl] (HU-210) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ascitic Fluid
Share to Benzoxazines
Share to Enterotoxins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Morpholines

Share to Naphthalenes

Share to Peritonitis

Share to Receptors, Drug

Share to Specific Pathogen-Free Organisms

Source

Identifiers

PMID: 11734194
DOI: 10.1016/s0014-2999(01)01477-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models.PMID 11734194Read ↗

Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis.Semantic proximity Read ↗

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis.Semantic proximity Read ↗

Adjuvant Cannabinoid Receptor Type 2 Agonist Modulates the Polarization of Microglia Towards a Non-Inflammatory Phenotype in Experimental Pneumococcal Meningitis.Semantic proximity Read ↗

The CB2 receptor and its role as a regulator of inflammationSemantic proximity Read ↗

MICROGLIAL CELL EXPRESSION OF THE TYPE 2 CANNABINOID RECEPTOR REGULATES IMMUNE-MEDIATED NEUROINFLAMMATIONSemantic proximity Read ↗

Cannabinoid CB2R regulates T cell gut-homing in preclinical Crohns model.Semantic proximity Read ↗

Protective role of cannabinoid receptor 2 activation in galactosamine/lipopolysaccharide-induced acute liver failure through regulation of macrophage polarization and microRNAs.Semantic proximity Read ↗

Orally bioavailable CB2 receptor agonists attenuate neuroinflammation and stabilize the blood–brain barrierSemantic proximity Read ↗

Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and diseaseSemantic proximity Read ↗

Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.Semantic proximity Read ↗

Cannabinoids decrease the th17 inflammatory autoimmune phenotype.Semantic proximity Read ↗

Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.